B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

BDH2

MOLECULAR TARGET

3-hydroxybutyrate dehydrogenase 2

UniProt: Q9BUT1NCBI Gene: 568981 compounds

BDH2 (3-hydroxybutyrate dehydrogenase 2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting BDH2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Bilirubin0.691

About BDH2 as a Drug Target

BDH2 (3-hydroxybutyrate dehydrogenase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented BDH2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

BDH2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.